These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9039176)

  • 1. Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Turiansky G; Wagner KF
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):239-42. PubMed ID: 9039176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS.
    Flaitz CM; Nichols CM; Hicks MJ
    Eur J Cancer B Oral Oncol; 1995 Jul; 31B(4):280-5. PubMed ID: 7492927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intralesional injection of vinblastine in treatment of laryngeal Kaposi sarcoma associated with AIDS].
    Gras R; Moulin G; Giovanni A; Chagnaud C; Triglia JM; Zanaret M
    Ann Otolaryngol Chir Cervicofac; 1999 Oct; 116(5):291-4. PubMed ID: 10572593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional vinblastine injections for the treatment of oral Kaposi's sarcoma: report of 10 patients with 2-year follow-up.
    McCormick SU
    J Oral Maxillofac Surg; 1996 May; 54(5):583-7; discussion 588-9. PubMed ID: 8632242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional vinblastine injections for treatment of classic Kaposi sarcoma in diabetic patients.
    Vassallo C; Carugno A; Derlino F; Ciocca O; Brazzelli V; Borroni G
    Cutis; 2015 May; 95(5):E28-34. PubMed ID: 26057517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iontophoresis of vinblastine into normal skin and for treatment of Kaposi's sarcoma in human immunodeficiency virus-positive patients. The Military Medical Consortium for Applied Retroviral Research.
    Smith KJ; Konzelman JL; Lombardo FA; Skelton HG; Holland TT; Yeager J; Wagner KF; Oster CN; Chung R
    Arch Dermatol; 1992 Oct; 128(10):1365-70. PubMed ID: 1417025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection.
    Boudreaux AA; Smith LL; Cosby CD; Bason MM; Tappero JW; Berger TG
    J Am Acad Dermatol; 1993 Jan; 28(1):61-5. PubMed ID: 8381146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonographic intraoperative monitoring and follow-up of Kaposi's sarcoma nodules under treatment with intralesional vincristine.
    Nazzaro G; Genovese G; Tourlaki A; Passoni E; Berti E; Brambilla L
    Skin Res Technol; 2019 Mar; 25(2):200-203. PubMed ID: 30311687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional vinblastine for treating AIDS-associated Kaposi's sarcoma of the oropharynx and larynx.
    Friedman M; Venkatesan TK; Caldarelli DD
    Ann Otol Rhinol Laryngol; 1996 Apr; 105(4):272-4. PubMed ID: 8604887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A juvenile case of classic Kaposi's sarcoma.
    Erdem T; Atasoy M; Akdeniz N; Parlak M; Ozdemir S
    Acta Derm Venereol; 1999 Nov; 79(6):492-3. PubMed ID: 10598779
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of oral Kaposi sarcoma with intralesional vinblastine.
    Epstein JB
    Cancer; 1993 Mar; 71(5):1722-5. PubMed ID: 8448735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Kaposi's sarcoma with vinblastine.
    Klein E; Schwartz RA; Laor Y; Milgrom H; Burgess GH; Holtermann OA
    Cancer; 1980 Feb; 45(3):427-31. PubMed ID: 7353196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine.
    Epstein JB; Lozada-Nur F; McLeod WA; Spinelli J
    Cancer; 1989 Dec; 64(12):2424-30. PubMed ID: 2819653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of disseminated cutaneous classic Kaposi's sarcoma with vinblastine.
    Turk HM; Buyukberber S; Camci C; Inaloz HS; Sari I; Kirtak N; Uner A
    J Dermatol; 2002 Oct; 29(10):657-60. PubMed ID: 12432999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease.
    Zidan J; Robenstein W; Abzah A; Taman S
    Isr Med Assoc J; 2001 Apr; 3(4):251-3. PubMed ID: 11344835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional vinblastine in the treatment of oral Kaposi's sarcoma.
    Moyle G; Youle M; Barton S
    Br J Clin Pract; 1993; 47(2):79-80. PubMed ID: 8334068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients.
    Brambilla L; Bellinvia M; Tourlaki A; Scoppio B; Gaiani F; Boneschi V
    Br J Dermatol; 2010 Apr; 162(4):854-9. PubMed ID: 19995366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of vinblastine and bleomycin as first line therapy in advanced classic Kaposi's sarcoma.
    Brambilla L; Miedico A; Ferrucci S; Romanelli A; Brambati M; Vinci M; Tedeschi L; Boneschi V
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1090-4. PubMed ID: 16987264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the treatment of Kaposi's sarcoma with vinblastine in Togo: a study of 23 cases].
    Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Balaka A; Pitché P; Tchangaï-Walla K
    Bull Soc Pathol Exot; 2011 Dec; 104(5):339-41. PubMed ID: 21359830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment modalities for intraoral Kaposi's sarcoma: report of case.
    Chockley B; Coke JM
    Spec Care Dentist; 1991; 11(6):231-3. PubMed ID: 1839938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.